NO153135C - Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.Info
- Publication number
- NO153135C NO153135C NO794069A NO794069A NO153135C NO 153135 C NO153135 C NO 153135C NO 794069 A NO794069 A NO 794069A NO 794069 A NO794069 A NO 794069A NO 153135 C NO153135 C NO 153135C
- Authority
- NO
- Norway
- Prior art keywords
- phenoxylycyl
- preparation
- therapeutic effective
- analogy procedure
- imidazold
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7848367 | 1978-12-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO794069L NO794069L (no) | 1980-06-16 |
| NO153135B NO153135B (no) | 1985-10-14 |
| NO153135C true NO153135C (no) | 1986-01-22 |
Family
ID=10501705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO794069A NO153135C (no) | 1978-12-13 | 1979-12-12 | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US4602016A (nl) |
| JP (1) | JPS585197B2 (nl) |
| KR (1) | KR830001243B1 (nl) |
| AR (1) | AR227637A1 (nl) |
| AT (1) | AT373879B (nl) |
| AU (1) | AU517892B2 (nl) |
| BE (1) | BE880584A (nl) |
| CA (1) | CA1108137A (nl) |
| CH (1) | CH644597A5 (nl) |
| CS (1) | CS216517B2 (nl) |
| DD (1) | DD147943A5 (nl) |
| DE (1) | DE2950019A1 (nl) |
| DK (1) | DK471479A (nl) |
| EG (1) | EG14227A (nl) |
| ES (1) | ES8101556A1 (nl) |
| FI (1) | FI70888C (nl) |
| FR (1) | FR2444031A1 (nl) |
| GB (1) | GB2038821B (nl) |
| GR (1) | GR73003B (nl) |
| HU (1) | HU183016B (nl) |
| IE (1) | IE49318B1 (nl) |
| IL (1) | IL58917A (nl) |
| IT (1) | IT1194900B (nl) |
| LU (1) | LU81985A1 (nl) |
| NL (1) | NL177749C (nl) |
| NO (1) | NO153135C (nl) |
| NZ (1) | NZ192360A (nl) |
| PH (1) | PH15056A (nl) |
| PL (1) | PL134005B1 (nl) |
| PT (1) | PT70571A (nl) |
| SE (1) | SE444937B (nl) |
| SU (1) | SU878195A3 (nl) |
| YU (1) | YU301879A (nl) |
| ZA (1) | ZA796708B (nl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4350696A (en) | 1980-03-08 | 1982-09-21 | Pfizer Inc. | Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof |
| US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| JPS58113178A (ja) * | 1981-12-28 | 1983-07-05 | Yamanouchi Pharmaceut Co Ltd | 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体 |
| US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
| US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
| NL8301550A (nl) * | 1983-05-03 | 1984-12-03 | Gist Brocades Nv | Imidazolethanol esters. |
| US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| IT1212791B (it) * | 1983-11-24 | 1989-11-30 | Medea Res Srl | Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono. |
| ES539074A0 (es) * | 1984-12-10 | 1985-11-16 | Ferrer Int | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. |
| JPH0625141B2 (ja) * | 1985-01-16 | 1994-04-06 | 三共株式会社 | イミダゾ−ル誘導体およびその製法 |
| NO166644C (no) | 1986-01-28 | 1991-08-21 | Sankyo Co | Analogifremgangsmaate til fremstilling av tianaftenderivater. |
| DE3786030T2 (de) | 1986-03-27 | 1993-12-02 | Merck Frosst Canada Inc | Tetrahydrocarbazole Ester. |
| JPS63179840A (ja) * | 1986-07-24 | 1988-07-23 | Yamanouchi Pharmaceut Co Ltd | 新規化学物質 |
| DE3860908D1 (de) * | 1987-04-03 | 1990-12-06 | Cl Pharma | Neue 2-thienyloxyessigsaeurederivate, ein verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. |
| JPH01125372A (ja) * | 1988-09-12 | 1989-05-17 | Yamanouchi Pharmaceut Co Ltd | イミダゾリルアルキルオキシベンゼン誘導体 |
| DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
| WO1999045905A2 (en) * | 1998-03-13 | 1999-09-16 | Pozen Inc. | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
| ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
| US20050020657A1 (en) * | 2002-07-09 | 2005-01-27 | B.M.R.A. Corporation B.V. | Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2 |
| AU2004264722A1 (en) * | 2003-08-07 | 2005-02-24 | B.M.R.A. Corporation B.V. | Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1 |
| KR101275814B1 (ko) * | 2006-06-23 | 2013-06-18 | 삼성에스디아이 주식회사 | 분산제 화합물 및 그의 제조방법 |
| JP2011517313A (ja) | 2007-12-11 | 2011-06-02 | ビアメト ファーマシューティカルズ，インク． | 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤 |
| CN101811974B (zh) * | 2010-04-15 | 2012-12-12 | 合肥医工医药有限公司 | 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途 |
| CN101851209B (zh) * | 2010-06-21 | 2012-09-19 | 合肥医工医药有限公司 | 咪唑乙基香草酸醚、其制备方法及其医药用途 |
| AR091112A1 (es) * | 2012-05-22 | 2015-01-14 | Genentech Inc | Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7 |
| CN104869992A (zh) | 2012-10-26 | 2015-08-26 | 默沙东公司 | 具有电压门控性钠通道选择性活性的n-取代的吲唑磺酰胺化合物 |
| CN114736161B (zh) * | 2022-06-13 | 2022-09-13 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
| WO2023240378A1 (zh) * | 2022-06-13 | 2023-12-21 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3534061A (en) * | 1967-12-04 | 1970-10-13 | Parke Davis & Co | N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles |
| US4085209A (en) * | 1975-02-05 | 1978-04-18 | Rohm And Haas Company | Preparation and safening effect of 1-substituted imidazole metal salt complexes |
| US4078071A (en) * | 1976-03-08 | 1978-03-07 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkyl imidazoles |
| JPS5951943B2 (ja) * | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
-
1979
- 1979-11-07 DK DK471479A patent/DK471479A/da not_active Application Discontinuation
- 1979-11-19 US US06/095,755 patent/US4602016A/en not_active Expired - Lifetime
- 1979-12-10 AR AR279215A patent/AR227637A1/es active
- 1979-12-10 GB GB7942535A patent/GB2038821B/en not_active Expired
- 1979-12-11 NZ NZ192360A patent/NZ192360A/xx unknown
- 1979-12-11 IL IL58917A patent/IL58917A/xx unknown
- 1979-12-11 SE SE7910204A patent/SE444937B/sv unknown
- 1979-12-11 FI FI793868A patent/FI70888C/fi not_active IP Right Cessation
- 1979-12-11 ES ES486782A patent/ES8101556A1/es not_active Expired
- 1979-12-11 HU HU79PI699A patent/HU183016B/hu unknown
- 1979-12-11 NL NLAANVRAGE7908899,A patent/NL177749C/nl not_active IP Right Cessation
- 1979-12-11 PT PT70571A patent/PT70571A/pt unknown
- 1979-12-11 YU YU03018/79A patent/YU301879A/xx unknown
- 1979-12-11 ZA ZA00796708A patent/ZA796708B/xx unknown
- 1979-12-11 IT IT41669/79A patent/IT1194900B/it active
- 1979-12-11 GR GR60727A patent/GR73003B/el unknown
- 1979-12-12 JP JP54161382A patent/JPS585197B2/ja not_active Expired
- 1979-12-12 EG EG743/79A patent/EG14227A/xx active
- 1979-12-12 SU SU792854456A patent/SU878195A3/ru active
- 1979-12-12 PL PL1979220351A patent/PL134005B1/pl unknown
- 1979-12-12 BE BE0/198542A patent/BE880584A/fr not_active IP Right Cessation
- 1979-12-12 IE IE2403/79A patent/IE49318B1/en unknown
- 1979-12-12 FR FR7930438A patent/FR2444031A1/fr active Granted
- 1979-12-12 LU LU81985A patent/LU81985A1/fr unknown
- 1979-12-12 CA CA341,691A patent/CA1108137A/en not_active Expired
- 1979-12-12 NO NO794069A patent/NO153135C/no unknown
- 1979-12-12 AU AU53725/79A patent/AU517892B2/en not_active Ceased
- 1979-12-12 DE DE19792950019 patent/DE2950019A1/de not_active Ceased
- 1979-12-12 AT AT0783379A patent/AT373879B/de not_active IP Right Cessation
- 1979-12-12 KR KR1019790004397A patent/KR830001243B1/ko active
- 1979-12-12 CS CS798708A patent/CS216517B2/cs unknown
- 1979-12-13 DD DD79217645A patent/DD147943A5/de unknown
- 1979-12-13 PH PH23412A patent/PH15056A/en unknown
- 1979-12-13 CH CH1106279A patent/CH644597A5/de not_active IP Right Cessation
-
1985
- 1985-03-21 US US06/714,422 patent/US4636500A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO153135C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater. | |
| NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
| NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO157817C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater. | |
| NO152215C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler | |
| NO149962C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
| NO151588C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater | |
| NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
| NO153136C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater. | |
| NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
| NO152935C (no) | Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. | |
| NO154522C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. | |
| NO166320C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO149312C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin | |
| NO149999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider. | |
| NO152255C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere | |
| NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner | |
| NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO150158C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater | |
| NO155539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater. | |
| NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
| NO155054C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-amino-1-benzoxepin-5(2h)-derivater. |